| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 152, 565-576, Copyright © 1998 by American Society for Investigative Pathology
REGULAR ARTICLES |
AE Kossakowska, A Hinek, DR Edwards, MS Lim, CL Zhang, DR Breitman, C Prusinkiewicz, AL Stabbler, LS Urbanski and SJ Urbanski
Department of Pathology, University of Calgary, Alberta, Canada. anna.kossakowska@crha-health.ab.ca
This study was conducted to assess the net proteolytic activity of human non-Hodgkin's lymphomas (NHLs). We have compared the extracellular matrix (ECM)-degradative abilities of human NHLs, reactive lymphoid hyperplasias, and established lymphoid cell lines using Matrigel invasion and elastin degradation assays. The inhibition studies allowed identification of the classes of proteinases involved in ECM degradation. Our results indicate that lymphocytes and other leukocytes derived from both human NHLs and reactive lymphoid hyperplasias are capable of Matrigel penetration, but only cells derived from the high-grade human NHLs degrade elastin in vitro. Established lymphoid cell lines (both malignant and Epstein-Barr virus immortalized) do not produce MMP-9, do not penetrate the Matrigel, and do not degrade elastin. Moreover, in human NHLs, elastolytic activity is blocked by metalloproteinase inhibitors, while inhibitors of the other classes of proteolytic enzymes have only minor effects. This study identifies metalloproteinases as the most important class of proteinases involved in ECM degradation by NHLs. The previous studies suggest that, within this class, MMP-9 represents the key enzyme that plays a role in the biological aggressiveness of human NHLs.
This article has been cited by other articles:
 |
|
 |
|
  M. Demers, T. Magnaldo, and Y. St-Pierre A Novel Function for Galectin-7: Promoting Tumorigenesis by Up-regulating MMP-9 Gene Expression Cancer Res., June 15, 2005; 65(12): 5205 - 5210. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ruddell, P. Mezquita, K. A. Brandvold, A. Farr, and B. M. Iritani B Lymphocyte-Specific c-Myc Expression Stimulates Early and Functional Expansion of the Vasculature and Lymphatics during Lymphomagenesis Am. J. Pathol., December 1, 2003; 163(6): 2233 - 2245. [Abstract] [Full Text]
|
|
|
|
 |
|
 N. Mori, H. Sato, T. Hayashibara, M. Senba, T. Hayashi, Y. Yamada, S. Kamihira, S. Ikeda, Y. Yamasaki, S. Morikawa, et al. Human T-cell leukemia virus type I Tax transactivates the matrix metalloproteinase-9 gene: potential role in mediating adult T-cell leukemia invasiveness Blood, February 15, 2002; 99(4): 1341 - 1349. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. De Noncourt, O. Robledo, T. Alain, A. E. Kossakowska, S. J. Urbanski, E. F. Potworowski, and Y. St-Pierre Leukocyte elastase in murine and human non-Hodgkin lymphomas J. Leukoc. Biol., October 1, 2001; 70(4): 585 - 591. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. K. Narla, Y. Dong, D. Klis, and F. M. Uckun Bis(4,7-dimethyl-1,10-phenanthroline) Sulfatooxovanadium(IV) as a Novel Antileukemic Agent with Matrix Metalloproteinase Inhibitory Activity Clin. Cancer Res., April 1, 2001; 7(4): 1094 - 1101. [Abstract] [Full Text]
|
|
|
|
 |
|
 J R Flavell, K R N Baumforth, D M Williams, M Lukesova, J Madarova, V Noskova, J Prochazkova, D Lowe, Z Kolar, P G Murray, et al. Expression of the matrix metalloproteinase 9 in Hodgkin's disease is independent of EBV status Mol. Pathol., June 1, 2000; 53(3): 145 - 149. [Abstract] [Full Text]
|
|
|
|
|
|
A. E. Kossakowska, D. R. Edwards, C. Prusinkiewicz, M. C. Zhang, D. Guo, S. J. Urbanski, T. Grogan, L. A. Marquez, and A. Janowska-Wieczorek Interleukin-6 Regulation of Matrix Metalloproteinase (MMP-2 and MMP-9) and Tissue Inhibitor of Metalloproteinase (TIMP-1) Expression in Malignant Non-Hodgkin's Lymphomas Blood, September 15, 1999; 94(6): 2080 - 2089. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Janowska-Wieczorek, L. A. Marquez, J.-M. Nabholtz, M. L. Cabuhat, J. Montano, H. Chang, J. Rozmus, J. A. Russell, D. R. Edwards, and A. R. Turner Growth Factors and Cytokines Upregulate Gelatinase Expression in Bone Marrow CD34+ Cells and Their Transmigration Through Reconstituted Basement Membrane Blood, May 15, 1999; 93(10): 3379 - 3390. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Vacca, D. Ribatti, M. Presta, M. Minischetti, M. Iurlaro, R. Ria, A. Albini, F. Bussolino, and F. Dammacco Bone Marrow Neovascularization, Plasma Cell Angiogenic Potential, and Matrix Metalloproteinase-2 Secretion Parallel Progression of Human Multiple Myeloma Blood, May 1, 1999; 93(9): 3064 - 3073. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
